CVR PARTNERS, LP

CVR PARTNERS, LP: Understanding a Key Governance Change

For investors in CVR Partners, LP, staying informed without getting lost in financial jargon is crucial. Here's a straightforward explanation of the company's recent material event and what it means for you.

1. The Core Event: What Happened?

CVR Partners, LP, a company producing essential fertilizers, recently experienced an unexpected and significant event. Brian A. Goebel, a vital independent director and Chairman of its Audit Committee, passed away.

This event directly impacts the company's listing on the New York Stock Exchange (NYSE). NYSE rules mandate that a company's Audit Committee must comprise at least three independent directors. Following Mr. Goebel's passing, CVR Partners' Audit Committee now has only two independent members, which means the company is temporarily out of compliance with NYSE Listing Standard 303A.07(a).

To illustrate, imagine a sports team needing a minimum number of players on the field to meet league rules. CVR Partners has lost a crucial player and must now quickly find a replacement to restore compliance.

2. The Timeline

Here’s a clear sequence of events:

• Mr. Goebel passed away on February 20, 2026.
• CVR Partners announced his passing and the resulting NYSE non-compliance on February 25, 2026.
• The company received official notice from the NYSE regarding its non-compliance on March 3, 2026.

3. Why It Happened: The Context

The direct cause of this situation is the unexpected passing of Brian A. Goebel. As an "independent director," he provided crucial, unbiased oversight because he was not an employee or closely tied to the company's management. His position as Chairman of the Audit Committee was especially significant. His passing immediately reduced the number of independent directors on that committee below the NYSE's required minimum, triggering this technical compliance issue.

4. Why This Matters: Impact & Risks

For investors, this raises the critical "so what?" question:

• Governance, Not Operations: Understand that this is a governance issue, not a problem affecting the company's core business operations, fertilizer production, or financial performance. CVR Partners' ability to make and sell fertilizer remains unaffected.
• NYSE Listing at Stake: However, this is a serious regulatory matter. Maintaining NYSE compliance is crucial for CVR Partners. Failure to resolve this carries the ultimate risk of delisting from the NYSE, which would be a significant setback.
• Potential Financial Implications of Delisting: While not an immediate financial crisis, delisting could lead to:
  • Reduced Liquidity: Investors would find it harder to buy and sell units.
  • Lower Unit Price: Delisted companies often experience unit price declines.
  • Difficulty Raising Capital: Access to capital markets could challenge the company.
  • Loss of Institutional Investor Interest: Many institutional investors only invest in exchange-listed securities.
• Investor Confidence: Strong corporate governance builds investor confidence. Swift resolution demonstrates the company's commitment to regulatory standards and investor protection.
• Distributions: As a limited partnership, CVR Partners typically aims to distribute a significant portion of its earnings to unitholders. This event does not directly impact its short-term ability to generate earnings or make distributions, but long-term listing stability supports overall investor value.

5. Who Is Affected?

• Investors (Unitholders): You, as unitholders, are most directly affected. Your investment's liquidity and value depend on the company maintaining its NYSE listing.
• Employees, Customers (Farmers), Suppliers, and Local Communities: Direct impact on these groups is likely minimal. This board-level compliance issue does not immediately affect day-to-day operations, production, or sales.

6. The Path Forward: What Happens Next?

CVR Partners is actively working towards a resolution:

• Immediate Action: The company has already notified the NYSE and publicly disclosed the situation, demonstrating transparency.
• Cure Period: The NYSE typically grants a 180-day cure period for such issues. CVR Partners therefore has until approximately August 30, 2026 (180 days from the March 3, 2026 notice) to regain compliance.
• Company's Plan: CVR Partners intends to regain compliance within this timeframe by actively searching for and appointing a new independent director to fill the vacancy on the Board and the Audit Committee "as soon as reasonably practicable."
• Resolution: Once the company appoints a suitable independent director who meets NYSE requirements, it will notify the NYSE and regain compliance.
• Failure to Comply: Should the company fail to regain compliance within the 180-day period, the NYSE could initiate delisting procedures.

7. Practical Takeaways for Investors

Here are key takeaways for investors:

• Stay Calm, But Be Aware: This is a governance challenge, not an operational or immediate financial crisis. However, the potential consequences of unresolved non-compliance are significant.
• Monitor for Resolution: Watch for the announcement of a new independent director appointment, which will signal the issue's resolution.
• Understand the Timeline: Note the 180-day cure period (ending around August 30, 2026), which sets a clear deadline for the company.
• Focus on Listing Stability: The primary concern is maintaining the company's NYSE listing, vital for unit liquidity, investor confidence, and capital access.
• Do Your Own Research: While this summary offers key insights, always supplement it with your own research into CVR Partners' financial health, industry trends (e.g., natural gas prices, crop demand), and broader market conditions before making investment decisions.

This event underscores the importance of strong corporate governance for any publicly traded company.